Eli Lilly has launched its blockbuster diabetes and weight-loss drug Mounjaro in India following approval from the country's ...

Eli Lilly launches Mounjaro in India following drug regulator approval, targeting diabetes and weight-loss in a rapidly ...

Eli Lilly has launched its blockbuster diabetes and weight-loss drug Mounjaro in India following approval from the country’s ...

U.S.-based pharmaceutical giant Eli Lilly has officially launched its widely popular drug, Mounjaro, in India. Containing the ...

The drug has seen strong demand in the US and Europe, and its India launch is part of Lilly’s broader strategy to expand ...

Once-a-weekly, prescription-based medicine, Mounjaro is a single molecule that selectively binds to and activates both GIP ...

Lilly launches Mounjaro in India, offering new option to treat obesity and type 2 diabetes: Our Bureau, Bengaluru Thursday, March 20, 2025, 13:30 Hrs [IST] Eli Lilly and Company l ...

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India-here's what ...

The drug, typically taken once a week, would cost between Rs 14,000 and Rs 17,500 per month, depending on the dosage ...

Popular anti-diabetes and obesity drug Mounjaro has been launched in India, by the US-based pharmaceutical giant Eli Lilly, ...

Novartis and Winselow Tucker, president and general manager, Lilly India who will discuss the key opportunities and challenges for the life sciences in Indian and overseas markets and the disruptive ...

APMA region of Novartis Cesar Concepcion and president and general manager of Lilly India Winselow Tucker. They will be discussing the key opportunities and challenges for the life sciences in ...